Abstract
Galectins are a large family of structurally related β-galactoside-binding proteins that play a pivotal role in the control of cell differentiation, proliferation, activation and apoptosis of many different cell types including immune cells. By crosslinking specific glycoconjugates, different members of the galectin family behave as pro-inflammatory or anti-inflammatory “cytokine-like” mediators, acting at different levels of innate and adaptive immune responses. Here we will review recent advances on the role of galectins in key events of the immune and inflammatory response, such as tolerance induction, cell cycle progression, cell adhesion, chemotaxis, antigen presentation and apoptosis. In particular we will examine the influence of individual members of the galectin family in the physiology of different immune cell types involved in innate and adaptive immune responses. Moreover, we will discuss the importance of these sugar-binding proteins as therapeutic targets in Th1- and Th2-mediated immune disorders, an exciting area for future research. Published in 2004.
Similar content being viewed by others
References
Cooper DNW, Galectinomics: Finding themes in complexity, Biochim Biophys Acta 1572, 209-31 (2002).
Liu F-T, Galectins: A new family of regulators of inflammation, Clin Immunol 97, 79–88 (2000).
Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu F-T, Iacobelli S, Galectins and their ligands: Amplifiers, silencers or tuners of the inflammatory response, Trends Immunol 23, 313- 20 (2002).
Rabinovich GA, Rubinstein N, Fainboim L, Unlocking the secrets of galectins: A challenge at the frontiers of glyco-immunology, J Leukoc Biol 71, 791-7 (2002).
Blaser C, Kaufmann M, Muller C, Zimmermann C, Wells V, Malluci L, Pircher H, β-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells, Eur J Immunol 28, 2311-9 (1998).
Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff M, Eberlein TJ, Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes, J Leukoc Biol 69, 555-64 (2001).
Rabinovich GA, Ramhorst RE, Rubinstein N, Corigliano A, Daroqui MC, Kier-Joffé EB, Fainboim L, Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms, Cell Death Diff 9, 661-70 (2002).
Matsumoto R, Hirashima M, Kita H, Gleich GJ, Biological activities of ecalectin: A novel eosinophil-activating factor, J Immunol 168, 1961-7 (2002).
Zôuñiga EI, Rabinovich GA, Iglesias MM, Gruppi A, Regulated expression of galectin-1 during B cell activation and implications for T-cell apoptosis, J Leukoc Biol 70, 73-9 (2001).
Rabinovich GA, Castagna LF, Landa CA, Riera CM, Sotomayor CE, Regulated expression of a 16 kDa galectin-like protein in activated rat macrophages, J Leukoc Biol 59, 363-70 (1996).
Rabinovich GA, Iglesias MM, Modesti NM, Castagna LF, Todel CW, Riera CM, Sotomayor CE, Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T-cells: Biochemical and functional characterization, J Immunol 160, 4831-40 (1998).
Zuñiga E, Gruppi A, Hirabayashi J, Kasai KI, Rabinovich GA, Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: Modulation of microbicidal activity and survival, Infect Immun 69, 6804-12 (2001).
Sato S, Hughes RC, Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages, J Biol Chem 269, 4424-30 (1994).
Ackerman SJ, Corrette SE, Rosenberg HF, Bennet JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, Tenen DG, Molecular cloning and characterization of human eosinophil Charcot-Leyden cristal protein (lysophospholipase), J Immunol 150, 456- 68 (1993).
Dunphy JL, Barcham GJ, Bischof RJ, Young AR, Nash A, Meeusen EN, Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge, J Biol Chem 277, 14916-24 (2002).
Baum LG, Pang M, Perillo NL, Wu T, Delegaene A, Uittenbogaart CH, Fukuda M, Seilhamer JJ, Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 Oglycans on thymocytes and T lymphoblastoid cells, J Exp Med 181, 877-87 (1995).
Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y, Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis, J Exp Med 190, 385-97 (1999).
Santucci L, Fiorucci S, Cammilleri F, Servillo G, Federici B, Morelli A, Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice, Hepatology 31, 399-406 (2000).
Offner H, Celnik B, Bringman T, Casentini-Borocz D, Nedwin GE, Vanderbark A, Recombinant human β-galactoside-binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis, J Neuroimmunol 28, 177-84 (1990).
Rabinovich GA, Sotomayor CE, Riera CM, Bianco I, Correa SG, Evidence of a role for galectin-1 in acute inflammation, Eur J Immunol 30, 1331-9 (2000).
Sacchettini JC, Baum LG, Brewer CF, Multivalent proteincarbohydrate interactions. A new paradigm for supermolecular assembly and signal transduction, Biochemistry 40, 3009-15 (2001).
Rabinovich GA, Modesti NM, Castagna LF, Landa CA, Riera CM, Sotomayor CE, Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a β-galactoside-binding lectin, J Biochem 122, 365-73 (1997).
Allione A, Wells V, Forni G, Mallucci L, Novelli F, β-galactosidebinding protein [β-GBP] alters the cell cycle, up-regulates the expression of the α-and β-chains of the IFN-γ receptor, and triggers IFN-γ-mediated apoptosis of activated human T lymphocytes, J Immunol 161, 2114-9 (1998).
Novelli F, Allione A, Wells V, Forni G, Mallucci L, Negative cell cycle control of human T cells by beta-galactoside-binding protein [beta GBP]: Induction of programmed cell death in leukaemia cells, J Cell Physiol 178, 102-8 (1999).
Rabinovich GA, Ariel A, Hershkoviz R, Hirabayashi J, Kasai KI, Lider O, Specific inhibition of T-cell adhesion to extracellular matrix and pro-inflammatory cytokine secretion by human recombinant galectin-1, Immunology 97, 100-6 (1999).
Perillo NL, Pace KE, Seilhamer JJ, Baum LG, Apoptosis of T cells mediated by galectin-1, Nature 378, 736-9 (1995).
Rabinovich GA, Alonso CR, Sotomayor CE, Durand S, Bocco JL, Riera CM, Molecular mechanisms implicated in galectin-1-induced apoptosis: Activation of the AP-1 transcription factor and downregulation of Bcl-2, Cell Death Diff 7, 747-53 (2000).
Santucci L, Fiorucci S, Rubinstein N, Mencarelli A, Palazetti B, Federici B, Rabinovich GA, Morelli A, Galectin-1 suppresses experimental colitis in mice, Gastroenterology 124, 1381-94 (2003).
Harjacek M, Díaz-Cano S, Miguel M, Wolfe H, Maldonado C, Rabinovich GA, Expression of galectins-1 and-3 correlates with defective mononuclear cell apoptosis in patients with juvenile rheumatoid arthritis, J Rheumatol 28, 1914-22 (2001).
Levy G, Tarrab-Hazdai R, Teichberg VI, Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits, Eur J Immunol 13, 500-7 (1983).
Tuchiyama Y, Wada J, Zhang H, Morita Y, Hiragushi K, Hida K, Shikata K, Yamamura M, Kanwar YS, Makino H, Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats, Kidney Int 58, 1941-52 (1999).
Lutomski D, Joubert-Caron R, Lefebure C, Salama J, Belin C, Bladier D, Caron M, Anti-galectin-1 autoantibodies in serum of patients with neurological diseases, Clin Chim Acta 262, 131-8 (1997).
Giordanengo L, Gea S, Barbieri G, Rabinovich GA, Anti-galecitn-1 autoantibodies in human Trypanosoma cruzi infection: Differential expression of this β-galactoside-binding protein in cardiac Chagas' disease, Clin Exp Immunol 124, 266-73 (2001).
Jensen-Jarolim E, Neumann C, Oberhuber G, Gscheidlinger R, Neuchrist C, Reinisch W, Zuberi RI, Penner E, Liu F-T, Boltz-Nitulescu G, Anti-galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries, J Clin Immunol 21, 348-56 (2001).
Lim Y, Lee DY, Lee S, Park SY, Kim J, Cho B, Lee H, Kim HY, Lee E, Song YW, Jeoung DI, Identification of autoantibodies associated with systemic lupus erythematosus, Biochem Biophys Res Commun 295, 119-24 (2002).
Kuwabara I, Liu F-T, Galectin-3 promotes adhesion of human neutrophils to laminin, J Immunol 156, 3939-44 (1996).
Yang RY, Hsu DK, Liu F-T, Expression of galectin-3 modulates T cell growth and apoptosis, Proc Natl Acad Sci USA 93, 6737-42 (1996).
Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, Yamanaka T, Hirashima M, Liu F-T, Human galectin-3 is a novel chemoattract for monocytes and macrophages, J Immunol 165, 2156-64 (2000).
Zuberi RI, Frigeri LG, Liu F-T, Activation of rat basophilic leukemia cells by εBP, an IgE-binding endogenous lectin, Cell Immunol 156, 1-12 (1994).
Colnot C, Ripoche MA, Milon G, Montagutelli X, Crocker PR, Poirier F, Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice, Immunology 94, 290-6 (1998).
Hsu DK, Yang R-Y, Yu L, Pan Z, Salomon DR, Fung-Leung W-P, Liu F-T, Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses, AmJ Pathol 156, 1073-83 (2000).
Schneller M, Andre S, Cihak J, Kaltner H, Rademaker G, Haverkamp J, Thomas-Oates JE, Losch U, Gabius HJ, Differential binding of two chicken β-galactoside-specific lectins to homologous lymphocyte subpopulations and evidence for inhibitory activity of the dimeric lectin on stimulated T cells, Cell Immunol 166, 35-43 (1995).
Perillo NL, Uittenbogaart CH, Nguyen JT, Baum LG, Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes, J Exp Med 97, 1851-8 (1997).
Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS, Developmental regulated expression and apoptotic potential of galectin-9, a β-galactoside-binding lectin, J Clin Invest 99, 2452-61 (1997).
Walzel H, Blach M, Hirabayashi J, Kasai K, Brock J, Involvement of CD2 and CD3 in galectin-1-induced signaling in human Jurkat T-cells, Glycobiology 10, 131-40 (2000).
Fouillit M, Joubert-Caron R, Poirier F, Bourin P, Monostori E, Levi-Strauss M, Raphael M, Bladier D, Caron M, Regulation of CD45-signaling by galectin-1 in Burkitt lymphoma B cells, Glycobiology 10, 413-9 (2000).
Pace KE, Lee C, Stewart PL, Baum LG, Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1, J Immunol 163, 3801-11 (1999).
Pace KE, Hahn HP, Pang M, Nguyen JT, Baum LG, CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death, J Immunol 165, 2331-4 (2000).
Galvan M, Tsuboi S, Fukuda M, Baum LG, Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1, J Biol Chem 275, 16730-15737 (2000).
Nguyen JT, Evans DP, Galvan M, Pace KE, Leitenberg D, Bui TN, Baum LG, CD45 modulates galectin-1-induced T cell death: Regulation by expression of core 2-O-glycans, J Immunol 167, 5697-707 (2001).
Amano M, Galvan M, He J, Baum LG, The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation and T cell death, J Biol Chem 278, 7469-75 (2003).
Rappl G, Abken H, Muche JM, Sterry W, Tilgen W, Andre S, Kaltner H, Ugurel S, Gabius HJ, Reinhold U, CD4+ CD7? leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T cell death, Leukemia 16, 840-5 (2002).
Vespa GN, Lewis LA, Kozak KR, Moran M, Nguyen JT, Baum LG, Miceli MC, Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation, J Immunol 162, 799-806 (1999).
Chung CD, Patel VP, Moran M, Lewis LA, Miceli MC, Galectin-1 induces partial TCR ζ-chain phosphorylation and antagonizes processive TCR signal transduction, J Immunol 165, 3722-9 (2000).
Poirier F, Robertson EJ, Normal development of mice carrying null mutation in the gene encoding the L-14 S-type lectin. Development 119, 1229-36 (1983).
Moon BK, Lee YL, Battle P, Jessup JM, Raz A, Kim HR, Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: Implication of galectin-3 function during metastasis, Am J Pathol 159, 1055-60 (2001).
Kim HR, Lin HM, Birilan H, Raz A, Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells, Cancer Res 59, 4148-54 (1999).
Matarrese P, Tinari N, Semeraro ML, Natoli C, Iacobelli S, Malorni W, Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis, FEBS Lett 473, 311-5 (2000).
Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A, Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest, J Biol Chem 277, 6852-7 (2002).
Demetriou N, Granovsky M, Quaggin S, Dennis JW, Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation, Nature 409, 733-9 (2001).
Swarte VV, Mebius RE, Joziasse DH, van den Eijnden DH, Kraal G, Lymphocyte triggering via L-selectin leads to enhanced galectin-3-mediated binding to dendritic cells, Eur J Immunol 28, 2846-71 (1998).
Villa-Verde DM, Silva-Monteiro E, Jasiulionis MG, Farias-De Oliveira DA, Brentani, RR, Savino W, Chammas R, Galectin-3 modulates carbohydrate-dependent thymocyte interactions with the thymic microenvironment, Eur J Immunol 32, 1434-44 (2002).
Bernerd F, Sarasin A, Magnaldo T, Galectin-7 over-expression is associated with the apoptotic process in UVB-induced sunburn keratinotyes, Proc Natl Acad Sci USA 96, 11329-34 (1999).
Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R, Zick Y, Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis, J Cell Sci 113, 2385-97 (2000).
Yang RY, Hsu DK, Yu L, Ni J, Liu F-T, Cell cycle regulation by galectin-12, a new member of the galectin superfamily, J Biol Chem 276, 20252-60 (2001).
Gauthier L, Rossi B, Roux F, Termine E, Schiff C, Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) in synapse formation between pre-B and stromal cells and in pre-BCR triggering, Proc Natl Acad Sci USA 99, 13014-9 (2002).
Poirier F, Bourin P, Bladier D, Joubert-Caron R, Caron M, Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human B lymphoma cell line B136, Cancer Cell Int 1, 2-3 (2002).
Liu F-T, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson WR, Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages, Am J Pathol 147, 1016-28 (1995).
Correa SG, Sotomayor CE, Aoki MP, Maldonado CA, Rabinovich GA, Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory and activated macrophages, Glycobiology 13, 119-28 (2003).
Jeng KCG, Frigeri LG, Liu F-T, An endogenous lectin, galectin-3 [εBP/Mac-2] potentiates IL-1 production by human monocytes, Immunol Lett 42, 113-6 (1994).
Almkvist J, Dahlgren C, Leffler H, Karlsson A, Activation of the neutrophil nicotinamide adenine dinucleotide phosphate oxidase by galectin-1, J Immunol 168, 4034-41 (2002).
Karlsson A, Follin P, Leffler H, Dahigren C, Galectin-3 activates the NADPH oxidase in exudated but not peripheral blood neutrophils, Blood 91, 3430-8 (1998).
Sato S, Ouellet N, Pelletier I, Simard M, Rancourt A, Bergeron MG, Role of galectin-3 as an adhesion molecule for neutrophil extravasation during Streptococcal Pneumonia, J Immuno l 168, 1813-22 (2002).
Cortegano I, del Pozo V, Cardaba B, de Andres B, Gallardo S, DelAmo A, Arrieta I, Jurado A, Palomino P, Liu F-T, Lahoz C, Galectin-3 down-regulates IL-5 gene expression on different cell types, J Immunol 161, 385-9 (1998).
Delbrouck C, Doyen I, Belot N, Decaestecker C, Ghanooni R, de Lavareille A, Kaltner H, Choufani G, Danguy A, Vandenhoven G, Gabius HJ, Hassid S, Kiss R, Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration, Lab Invest 82, 147-58 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rabinovich, G.A., Toscano, M.A., Ilarregui, J.M. et al. Shedding light on the immunomodulatory properties of galectins: Novel regulators of innate and adaptive immune responses. Glycoconj J 19, 565–573 (2002). https://doi.org/10.1023/B:GLYC.0000014087.41914.72
Issue Date:
DOI: https://doi.org/10.1023/B:GLYC.0000014087.41914.72